Wells Fargo’s NeuroDerm Ltd. Ordinary Shares NDRM Stock Holding History

Wells Fargo’s Portfolio NDRM Stock Details NDRM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q4	–	Sell	-500	Closed	-$20K	–	6811
2017 Q3	$20K	Sell	500 -372,648	-100%	-$13.7M	﹤0.01%	5716
2017 Q2	$11.2M	Buy	373,148 +372,473	+55,181%	+$9.65M	﹤0.01%	1829
2017 Q1	$18K	Buy	675 +369	+121%	+$9.14K	﹤0.01%	5741
2016 Q4	$6K	Buy	+306	New	+$5.72K	﹤0.01%	5939
2016 Q2	–	Sell	-5,500	Closed	-$78K	–	6732
2016 Q1	$78K	Buy	5,500 +5,274	+2,334%	+$71.2K	﹤0.01%	5014
2015 Q4	$4K	Buy	226 +21	+10%	+$409	﹤0.01%	5950
2015 Q3	$4K	Buy	+205	New	+$4.21K	﹤0.01%	5921

Other funds holding NDRM

VOAM

Vertex One Asset Management Vancouver, British Columbia, Canada $434M AUM 37.82% 1-Year Est. Return

OTC

Opera Trading Capital Paris, France $419M AUM 0.58% 1-Year Est. Return

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

FWM

Focused Wealth Management Newburgh, New York $964M AUM 18.71% 1-Year Est. Return

Wells Fargo's NDRM Position: Q4 2017 in Review

Wells Fargo sold out of NeuroDerm Ltd. Ordinary Shares (NDRM) in Q4 2017, closing a stake of 500 shares — an estimated $20K sold.

Wells Fargo first reported a position in NDRM in Q3 2015 and held it in 7 quarters. The position peaked at $11.2M in Q2 2017. 5 funds tracked by Wall St. Rank hold NDRM as of Q4 2017.

Wells Fargo reported no remaining NeuroDerm Ltd. Ordinary Shares position as of Q4 2017 after selling out during the quarter.
Wells Fargo sold 500 NeuroDerm Ltd. Ordinary Shares shares in Q4 2017, an estimated $20K.
Wells Fargo first reported a position in NeuroDerm Ltd. Ordinary Shares in Q3 2015 and held it in 7 quarters.
Wells Fargo's NeuroDerm Ltd. Ordinary Shares position peaked at $11.2M in Q2 2017.
5 funds tracked by Wall St. Rank held NeuroDerm Ltd. Ordinary Shares as of Q4 2017.

Based on Wells Fargo's 13F filing for Q4 2017, filed 8 Feb 2018.